Cabaletta Bio (CABA) Current Leases (2022 - 2026)
Cabaletta Bio (CABA) posted quarterly Current Leases of $3.5 million for Q4 2025, down 13.17% year-over-year from $4.0 million in Q4 2024, and down 80.33% quarter-over-quarter from $17.6 million in Q3 2025.
Cabaletta Bio (CABA) Current Leases (2022 - 2026) Analysis & Trends
Cabaletta Bio's Current Leases history runs 4 years deep, the most recent figure standing at $3.5 million for Q4 2025.
- In Q4 2025, Current Leases fell 13.17% year-over-year to $3.5 million; the TTM figure through Dec 2025 stood at $3.5 million (down 13.17% YoY), while the FY2025 annual figure was $3.5 million, down 13.17% from the prior year.
- Current Leases for Q4 2025 stood at $3.5 million, down from $17.6 million in the prior quarter.
- The five-year high for Current Leases was $17.6 million in Q3 2025, with the low at $2.2 million in Q4 2022.
- The 4-year median for Current Leases is $4.0 million (2024), against an average of $5.3 million.
- The sharpest annual moves came in 2024 and 2025: Current Leases jumped 239.48% in 2024, then tumbled 46.16% in 2025.
- Cabaletta Bio's Current Leases stood at $2.2 million in 2022, then surged by 63.38% to $3.6 million in 2023, then increased by 11.97% to $4.0 million in 2024, then decreased by 13.17% to $3.5 million in 2025.
- Business Quant data shows CABA's Current Leases at $3.5 million in Q4 2025, $17.6 million in Q3 2025, and $4.0 million in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Leases (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 720.00 Mn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 11.00 Mn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | 16.75 Mn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 21.95 Mn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 2.24 Mn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 45.93 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 6.27 Mn |
| 10 | Cabaletta Bio | 466.25 Mn | 466.25 Mn | - | 15.24 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 15.24 Mn |
| Dec 31, 2025 | 3.46 Mn |
| Sep 30, 2025 | 17.60 Mn |
| Jun 30, 2025 | 3.99 Mn |
| Mar 31, 2025 | 3.99 Mn |
| Dec 31, 2024 | 3.99 Mn |
| Sep 30, 2024 | 7.94 Mn |
| Jun 30, 2024 | 7.40 Mn |
| Mar 31, 2024 | 7.40 Mn |
| Dec 31, 2023 | 3.56 Mn |
| Sep 30, 2023 | 2.52 Mn |
| Jun 30, 2023 | 2.18 Mn |
| Mar 31, 2023 | 2.18 Mn |
| Dec 31, 2022 | 2.18 Mn |